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ABSTRACT 
Objective: As a further part of our chemical and biological studies in this field, we describe the preparations of the properly substituted benzylidene-
bis-(4-hydroxycoumarin) derivatives 5a-h and 3-(6-oxo-(1H)-benzopyrano[4,3-b]benzopyran-7-yl)-4-hydroxycoumarin derivatives 6a-e. Methods: 
The synthesized compounds were screened for their in vitro antimicrobial activity against five strains of bacteria and two fungal strains using disk 
diffusion assay and dilution method. The way in which the substituent group’s physicochemical properties influence the antimicrobial activity is 
discussed in the paper. Results: The in vitro evaluation of their inhibitory properties towards five strains of Gram-positive and Gram-negative 
bacteria and two fungal strains indicated that the 4-trifluoromethylbenzylidene derivative of bis-(4-hydroxycoumarin) (compound 5c) and 3-(6-
oxo-(1H)-18-bromobenzopyrano[4,3-b]benzopyran-7-yl)-4-hydroxycoumarin derivative (compound 6b) possess the most potent antibacterial 
activities, with MIC of 3.9 μg/mL - 7.8 μg/mL against Gram-positive bacteria. Conclusion: The compound 6b has greater antibacterial activity than 
the standard chloramfenicol (inhibition zone 26 mm and MIC 1.9 μg/mL) against Staphyloccocus aureus and could be considered as leading 
compound in the future antimicrobial drug development. 
Keywords: Benzylidene-bis-(4-hydroxycoumarin), benzopyranocoumarin derivatives, antibacterial assays, antifungal activity. 
INTRODUCTION 
With the development of new strains of bacteria resistant to many 
currently available antibiotic treatments, there is increasing interest 
in the discovery of new antibacterial agents. Antimicrobial 
resistance refers to microorganism that have developed the ability 
to inactivate, exclude or block the inhibition or lethal mechanism of 
the antimicrobial agents [1]. 
The coumarin (2-oxo-2H-chromene) derivatives are quite 
interesting objects for both synthesis and pharmacological 
screening. Their reactivity towards nucleophiles provides a useful 
route to prepare a variety of rearranged products and new 
heterocyclic systems. A variety of synthesized coumarin derivatives 
have been experimentally shown to exert pharmacological activities 
including anticoagulant, antitumor and antiproliferative, anti-
inflammatory, antioxidative as well as antiviral activities [2-9]. A 
number of natural and synthetic coumarin derivatives have been 
reported to exert notably antimicrobial as well as antifungal activity 
[10-16]. 
Three main compounds of the aminocoumarin class of antibiotics, 
novobiocin, clorobiocin and coumermycin A1, are natural products 
of soil-dwelling bacteria called Streptomycetes. These compounds 
are potent inhibitors of DNA gyrase, an essential enzyme in bacteria 
and a validated drug target. However, due to their limited solubility 
in water, their low penetration into Gram-negative bacteria and 
their moderate toxicity to humans, they have not been widely 
applied clinically. Further derivation of novobiocin, clorobiocin, and 
coumermycin A1 has made the production of new coumarin 
antibiotics displaying excellent inhibition of DNA supercoiling by 
DNA gyrase B possible [17, 18]. 
A number of structurally different natural and synthetic coumarin 
derivatives have also been reported as the inhibitors of DNA gyrase 
[19, 20]. As noted, the antimicrobial action of the most of the 
coumarin compounds was related to inactivation of cellular 
enzymes, which depended on the substance penetration rate into the 
cell or caused by membrane permeability changes. Increased 
membrane permeability  is   a major   factor   in   the   mechanism   of  
 
antimicrobial action. The introduction of halogens, and in particular 
bromine, fluorine and fluoroalkyl substituents to coumarin moiety, 
has led to the enhancement of the lipophilicity. Lipophilicity is an 
important physicochemical parameter in the development of 
antibacterial agent because it is known to be closely related to the 
permeation through a lipid coat of bacteria [21-25]. Studies have 
also shown that the number and position of substitutions in the 
coumarin ring influenced the antimicrobial potential. 
In connection with our previous work [8, 13] on the synthesis of 
coumarins and the evaluation of antiviral activity in vitro, our 
present study is focused on the antimicrobial activity evaluation of 
the biscoumarins, with variously substituted aryl central linker. 
The present study has been focused mainly on the investigation of 
some benzylidene-bis-(4-hydroxycoumarin) derivatives with 
various substituents on the linker of phenyl ring (R= Br, F, CF3, SCH3, 
NO2, OH, OCH3) 5a-h as well as fused benzopyranocoumarin 
derivatives 6a-e for their antimicrobial activity evaluation.  The 
results indicated that the biscoumarin unit linked by a phenyl ring 
was required for the activity. 
MATERIALS AND METHODS 
General 
Series of benzylidene-bis-(4-hydroxycoumarin) derivatives 5a-h and 
fused benzopyranocoumarin derivatives 6a-d were prepared in 
moderately good yields by Claisen condensation of 4-
hydroxycoumarin and appropriate substituted aromatic aldehydes 
2a-h, all being commercially available 3-bromobenzaldehyde (2a), 
4-fluorobenzaldehyde (2b), 4-trifluoromethylbenzaldehyde (2c), 4-
nitrobenzaldehyde (2d), 4-methylthiobenzaldehyde (2e), 3,4-
dihydroxybenzaldehyde (2f), 2,5-dimethoxybenzaldehyde (2g) and 
4-hydroxy-3-methoxy-5-nitrobenzaldehyde (2h). 
Procedures for the preparation of compounds 
According to the previously published procedure [8] 4-
hydroxycoumarin (0.324 g, 2 mmol) was dissolved in hot ethanol (6 
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mL), the appropriate aldehyde (1 mmol) was added and the reaction 
mixture was refluxed for 24 h. After cooling to room temperature, 
the solid was filtered out and crystallized to give the product 
benzylidene-bis-(4-hydroxycoumarin) derivatives 5a-h and 3-(6-
oxo-(1H)-benzopyrano[4,3-b]benzopyran-7-yl)-4-hydroxycoumarin 
derivatives 6a-d (Scheme 1). 
Antimicrobial activity evaluation  
The synthesized compounds were screened for their in vitro 
antimicrobial activity against five strains of bacteria and two fungal 
strains using a disk diffusion assay and dilution method. For 
antibacterial screening various bacteria, Bacillus subtilis ATCC 6633, 
Staphylococcus aureus ATCC 6538P, Salmonella typhimurium ATCC 
14028, Escherichia coli ATCC 8739, Pseudomonas aeruginosa ATCC 
9027 were used. Antifungal activity was performed against Candida 
albicans ATCC 10231 and Saccharomyces cerevisiae ATCC 9763. Each 
tested strain  was previously grown in Triptic Soy Broth at 25 oC for 
24 h, and bacterial and fungi suspensions were adjusted to the 
turbidity of 0.5 McFarland (1.5 x 108 CFU/mL) with a sterile saline 
solution (0.85% NaCl). 
The screening results were compared with chloramphenicol for 
antibacterial and ketoconazole for antifungal activities respectively 
and dimethyl sulfoxide treated group served as a control.  
In vitro evaluation of antibacterial activity 
Mueller Hinton and Sabouraud medium were used for determination 
of antimicrobial activity (diffusion method). Biscoumarin derivatives 
disc diffusion method results were presented as the inhibition zones, 
given in millimeters (mm).  
When using the diffusion method, the test samples were dissolved in 
30% dimethyl sulfoxide (DMSO) to obtain a 1000 g/ml stock 
solution. Bacteria inhibition zones were measured in millimeters at 
the end of an incubation period of 18 h at 37 °C, and fungi zones 
after 48 h at 25 °C.  
The minimal inhibitory concentration (MIC) of the synthesized 
compounds was determined in vitro by the Soybean Casein Digest 
Broth (Triptic Soy Broth) by dilution method. 
The solution of the tested compounds was prepared by the dilution 
method for the analysis, followed by the formation of series of 12 
dilutions with liquid nutritious base. The 2.0 mL Casein Soya Bean 
digest broth was added to the 2.0 mL starting solution of test 
material and thus the first dilution was formed. Subsequently, 2.0 
mL of this solution was diluted with 2.0 mL Casein Soya Bean digest 
broth to give the second dilution and so on until 12 dilutions were 
obtained.  
After the incubation at 37 °C for 24 h, the first tube without turbidity 
was determined as the minimal inhibition concentration expressed 
in µg/mL. The concentrations of the prepared solutions were from 
500 µg/mL to 0.244 µg/mL. 
The aim of this method was to determine the lowest concentration 
of a tested compound resulting in no bacterial growth. This 
concentration was considered as Minimal Inhibition Concentration 
(MIC). The Bactericidal Concentration (BC) of each compound, and 
each bacterial strain, was considered as the lowest concentration of 
a drug required to kill a particular bacterium. 
RESULTS AND DISCUSSION  
Chemistry 
The benzylidene-bis-(4-hydroxycoumarin) derivatives 5a-h and 
fused benzopyranocoumarin derivatives 6a-e were prepared by a 
sequence of reactions displayed in the Scheme 1. In the first step of 
the synthesis the aldol condensation of 4-hydroxycoumarin (1) with 
an appropriately substituted aldehyde (2) linker followed by the 
dehydration of aldol product (3) gave a chromone (4). Subsequent in 
situ reaction of the chromon with 4-hydroxycoumarin already 
excessively present in the reaction mixture gave biscoumarin 
derivatives 5a-h bearing an aryl substituent in the central 
methylene linker. Also, the chromone derivatives containing an 
ortho substituted phenyl moiety (R = Cl, F, OH, OCH3) gave under 
spontaneous cyclization the fused benzopyranocoumarin derivatives 
6a-e. The compound 6i, described previously [13], was also 
synthesized for its antimicrobial activity evaluation.  
The synthesis and the chemical structure of the synthesized 
compounds are presented in Scheme 1. 
 
Scheme 1: The synthesis of biscoumarin derivatives with 
variously substituted aryl central linkers (5a-h) and fused 
benzopyranocoumarin derivatives (6a-e). Reagents and 
conditions: (i) EtOH, reflux, rt, 24 h. 
Analytical data of synthesized compounds (CHN analysis, IR, 1H/13C 
NMR, Mass spectrometry, X-ray crystallography) were presented in 
our previous paper [8]. 
Bactericidal and bacteriostatic activity 
The antimicrobial activities, given by the inhibition zone of the 14 
coumarin derivatives are shown in Table 1. 












5a 13 11 9 9 
5b 14 18 11 10 
5c 19 22 11 9.5 
5d - - 10 9 
5e 14 11 9.5 9 
5f - - 9 8 
5g 17 10 9 9 
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5h - - 11 8 
5i** 11 20 11 8 
6a - 17 10 10 
6b 19 25 9.5 9.5 
6c 11 12 10 10 
6d - - 9 8 
6e 11 16 10 8 
Chloramphenicol 25 23 - - 
Ketokonazole - - 15 14 
*Zone diameter of growth inhibition (mm) after 24 hours, at the concentration 1000 g/mL in DMSO   
 ** 3,3'-(4-Bromobenzylidene)-bis-(4-hydroxycoumarin) [13] 
The compounds which showed the best antimicrobial activity using 
the diffusion method were further tested by the dilution method. By 
dilution method we defined Minimum Bactericidal Concentration 
(MBC) and Minimum Inhibitory Concentration (MIC). The Minimum 
Bactericidal Concentration (MBC) and Minimum Inhibitory 
Concentration (MIC) were determined by the dilution method (Table 
2). 
 
Table 2: Antimicrobial activity of the biscoumarin compounds tested by dilution method 
Compound 
number 
Bacillus subtilis Staphylococcus aureus 
MBC (g/mL) MIC (g/mL) MBC (g/mL) MIC (g/mL) 
5a 62.5 31.25 62.5 31.25 
5b 31.25 15.6 15.6 7.8 
5c 15.6 7.8 15.6 3.9 
5e 62.5 15.6 62.5 31.25 
5g 31.25 15.6 62.5 31.2 
5i 31.25 7.8 15.6 7.8 
6a 62.5 31.25 31.25 15.6 
6b 7.8 1.95 7.8 3.9 
6c 62.5 31.25 62.5 31.25 
6e 62.5 31.25 31.25 15.6 
Chloramphenicol 7.8 3.9 7.8 3.9 
 
As a result of our previous work, the antimicrobial activity of some 
benzylidene-bis-(4-hydroxycoumarin) derivatives against certain 
Gram-positive bacteria was proved [13]. The result of the present 
study showed a broad range of antimicrobial activity. All of the 
coumarins exhibited activity against Gram-positive bacteria and 
fungi, and few of them were selectively active against one or two 
strains, whilst they displayed no activity against Gram-negative 
bacteria. Because of the permeability barrier provided by the outer 
membrane, Gram-negative bacteria are resistant to all of the tested 
compounds. 
The data found in the literature matching our research claims that 
the compounds with halogen substituent are the most efficient 
against Gram-positive bacteria, particularly against S. aureus [23, 
24]. Fluoro and trifluoromethylated coumarin compounds (5b, 5c) 
are of a particular interest since the strong electron-withdrawing 
effect of fluorine and trifluoromethyl groups contributes to 
molecule’s biological properties. The isosteric substitution of 
hydrogen by fluorine in coumarin compounds increases the 
lipophilicity and thus enhances the rate of cell penetration, which is 
a very important feature in drug efficiency.  
Compound 5c with trifluoromethyl substituent at the C-4 position on 
the linker of phenyl ring showed the best activity with MIC = 3.9 
g/mL against S. aureus, and with MIC = 7.8 g/mL against Bacillus 
subtilis. Compound 5b with fluorine at the C-4 position showed very 
strong activity with MIC = 7.8 g/mL against S. aureus, and strong 
activity with MIC = 15.6 g/mL against B. subtilis. 
Compounds 5a, 5b, 5c, 5e, 5i and 6b with the range of MIC = 3.9 - 
62.5 μg/mL showed antimicrobial activity against S. aureus at a 
relatively low concentration. 
Bromine at the C-4 (5i) and C-5 (6b) positions of phenyl ring 
significantly increases activity against S. aureus, while the bromine 
at the position C-3 (6a) of phenyl ring reduces the activity. 
Comparing their MICs with chloramphenicol, compound 5i showed 
similar level of activity and 6b showed higher level of activity when 
compared with standard drug. Of all the benzopyranocoumarin 
derivatives, 6b showed the best activity with MIC = 1.9 g/mL 
against S. aureus. 
 
Five evaluated compounds (5b, 5c, 5e, 5g and 6b) with MICs in the 
range MIC = 7.8 - 31.25 µg/mL showed relatively strong inhibitory 
activity against B. subtilis. The best activity was shown again by 
compounds with halogen substitents, 5c and 6b, with MIC = 7.8 
µg/mL. 
Moderate activity against B. subtilis was shown by the other 
compounds with methoxy (5g), fluorine (5b) and thiomethyl group 
(5e) on the linker of the phenyl ring, with MIC = 15.6 g/mL, MIC = 
15.6 g/mL and MIC = 31.25 g/mL, respectively.  
Methoxy derivative (6h) possesses moderate bioactivities against 
both Gram-positive bacteria. The hydroxyl derivative 5f showed no 
expected activity. Compound with hydroxy and nitro substituents 
(5d and 6d) proved to be completely inactive. 
All compounds were also evaluated for their antifungal activities 
against Candida albicans ATCC 10231 and Saccharomyces cerevisiae 
ATCC 9763. No specific antifungal effects were noted for any of the 
evaluated compounds. 
CONCLUSIONS 
A series of the benzylidene-bis-(4-hydroxycoumarin) derivatives 
(5a-e) and fused benzopyranocoumarin derivatives (6a-h) were 
synthesized and evaluated for their antimicrobial activities against 
five strains of Gram-positive and Gram-negative bacteria, and two 
strains of fungi.   
Synthesized coumarin derivatives generally possess strong or 
moderate activity against Gram-positive bacteria, S. aureus and B. 
subtillis, and show no activity to Gram-negative bacteria. The MIC 
results indicated that the antimicrobial activity of the investigated 
compounds was influenced by the physicochemical properties of the 
type and position of substituents on the linker of phenyl ring. Among 
the tested compounds, two structurally similar groups of 
derivatives, 5a-e and 6a-h, compounds 5c and 6b demonstrated 
enhanced activity against Gram-positive bacteria S. aureus and B. 
subtilis, with MICs in the range of 1.9 - 7.8 μg/mL, respectively, due 
to the influence of the bromine and trifluoromethyl substituents. 
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Results of this research could be considered as a useful base for the 
future development of potent antimicrobial agents against Gram-
positive bacteria, especially against Staphyloccocus aureus. 
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